Detalhe da pesquisa
1.
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Gynecol Oncol
; 182: 124-131, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262235
2.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Gynecol Oncol
; 187: 105-112, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759516
3.
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
Ann Surg Oncol
; 30(13): 8144-8155, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710139
4.
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet
; 397(10271): 281-292, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485453
5.
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.
Ann Surg Oncol
; 29(1): 175-185, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387765
6.
Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?
Gynecol Oncol
; 164(1): 39-45, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794840
7.
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
J Natl Compr Canc Netw
; 20(9): 972-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075393
8.
Germline mutations and age at onset of lung adenocarcinoma.
Cancer
; 127(15): 2801-2806, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858029
9.
Recall of Genomic Testing Results Among Patients with Cancer.
Oncologist
; 26(12): e2302-e2305, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355454
10.
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(2): 191-226, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545690
11.
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study.
Gynecol Oncol
; 158(3): 640-645, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513564
12.
LoRaWAN for Smart City IoT Deployments: A Long Term Evaluation.
Sensors (Basel)
; 20(3)2020 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31979377
13.
Monitoring Methylmalonic Aciduria by NMR Urinomics.
Molecules
; 25(22)2020 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33202577
14.
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 636-648, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948273
15.
Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?
J Natl Compr Canc Netw
; 17(8): 922-930, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390593
16.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
J Natl Compr Canc Netw
; 17(8): 896-909, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390583
17.
Antibody-drug conjugates for ovarian cancer: current clinical development.
Curr Opin Obstet Gynecol
; 31(1): 18-23, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30531606
18.
City Scale Particulate Matter Monitoring Using LoRaWAN Based Air Quality IoT Devices.
Sensors (Basel)
; 19(1)2019 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626131
19.
Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology.
Gynecol Oncol
; 151(1): 82-90, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30170976
20.
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies.
Gynecol Oncol
; 148(3): 507-514, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29352572